GLOBUS MEDICAL, INC. Accounts Receivable, Allowance for Credit Loss, Current
GLOBUS MEDICAL, INC. (GMED) had Accounts Receivable, Allowance for Credit Loss, Current of $44.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $44.37M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $40.93M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $33.43M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $27.41M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $44.37M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $40.93M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $33.43M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $27.41M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $26.61M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $8.49M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $15.51M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $23.54M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $19.26M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $11.53M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $8.93M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $9.24M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $6.25M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $5.51M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $4.72M 10-K · filed 2024-02-21 | |
| 2022-09-30 | $4.28M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.18M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.19M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $4.96M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $4.93M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $4.69M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $4.36M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $4.41M 10-K · filed 2022-02-17 | |
| 2020-09-30 | $7.01M 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $8.12M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $6.76M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $5.60M 10-K · filed 2021-02-17 | $5.60B 10-K · filed 2020-02-20 |
| 2019-09-30 | $6.56M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $5.41M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $4.24M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $4.23B 10-K/A · filed 2020-03-02 | $4.23M 10-K · filed 2019-02-21 |
| 2018-09-30 | $3.65M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.92M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $4.13M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $3.96M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $3.73M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.65M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $3.63M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.77M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $2.69M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.34M 10-Q · filed 2016-07-27 | |
| 2016-03-31 | $2.56M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $2.51M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.22M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $2.21M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $1.57M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $1.65M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $1.73M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $1.55M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $1.50M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $1.58M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $1.24M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $1.14M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $1.10M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $961.00K 10-K · filed 2014-03-14 | |
| 2012-09-30 | $931.00K 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $906.00K 10-Q/A · filed 2012-09-19 | |
| 2011-12-31 | $602.00K 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |